Beginning in 2022, businesses are now required to capitalize specified research and experimental expenditures  (“SRE expenditures“) and amortize (deduct) them over time.  Expenditures attributable to domestic research are amortized over five years and expenditures attributable to foreign research are amortized over 15 years.   SRE expenditures are generally research and development costs in an experimental or laboratory sense for product development or improvement and include software development costs.

If the property with respect to which the SRE expenditures are being amortized is sold, the business is not allowed to deduct the unamortized expenditures or use them to offset gain on the sale but must continue to deduct the amortization over the relevant period (i.e., 5 or 15 years).  For companies that have substantial unamortized SRE expenditures this could result in the practical loss of meaningful deductions if the company sells its business in an asset sale.  If, for example, the company is in its second year of a five-year amortization period, it will be required to deduct that amortization over the following three years.  Having sold its business, it may not have any income against which to apply the deductions.

Guidance released earlier this year in Notice 2023–63 provides some relief, allowing corporations that cease to exist i.e., dissolve (in a taxable transaction) to deduct the unamortized expenditures in its final tax year.  Accordingly, if the selling corporation can be liquidated in year of sale, it will be able to use the unamortized expenditures to offset sale gain.  If liquidation in the year of sale is not an option or the selling company is not a corporation, deferring payment of a portion of the purchase price might allow a seller to use unamortized expenditures more fully.  In addition, a seller’s receipt of equity of the buyer or an earnout may provide an opportunity to utilize the unamortized losses depending upon the timing and amount of the future income or gain.

Bottom Line:  For companies with substantial unamortized SRE expenditures, careful planning may be required to prevent the loss of those deductions.

“Every day I get up and look through the Forbes list of the richest people in America. If I’m not there, I go to work.” —Robert Orben

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of James Duffy James Duffy

Jim is a partner in Taft’s Tax practice and practices principally in the areas of federal tax law; tax credit financing; individual, partnership and corporate tax planning; M&A; tax-exempt organizations and general commercial and corporate law.

Jim has been actively practicing in the

Jim is a partner in Taft’s Tax practice and practices principally in the areas of federal tax law; tax credit financing; individual, partnership and corporate tax planning; M&A; tax-exempt organizations and general commercial and corporate law.

Jim has been actively practicing in the area of the New Markets Tax Credits (NMTC) program since its inception in 2001. He has organized community development entities (CDEs) and represented CDEs, borrowers and other parties in structuring and closing numerous NMTC transactions. Jim also advises clients regarding Qualified Opportunity Zone matters.

Jim advises LLCs, partnerships, corporations and individuals in connection with the formation of new companies, mergers and acquisitions, formation of joint ventures, like-kind exchanges, ownership succession planning, and general business operations. These clients are involved in a variety of industries, including banking, venture capital, real estate, construction, consulting and investing.

Jim also advises charitable and non-charitable tax-exempt organizations, including health care entities, schools, religious and civic organizations. In addition to advising management of these organizations with respect to matters pertaining to general operation and maintenance of tax-exempt status, Jim has assisted clients in forming, restructuring and dissolving tax-exempt organizations, as well as forming donor- advised funds.

Prior to joining the firm, Jim worked at the law firm of Lewis Rice and Fingersh in St. Louis, Missouri, where he concentrated his practice in federal and state taxation. He also clerked for the Hon. Robert P. Ruwe of the U.S. Tax Court in Washington, D.C.